ArticlePloS one2026
Integrating machine learning with SHAP to uncover multi-tissue molecular signatures in Osteoarthritis progression.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Decoding non-fullerene acceptors for organic solar cells: a theoretical structure-property-performance perspective.RSC advances · 2026Review
- An explainable ensemble machine learning framework for predicting cartilage biomechanical degradation from transcriptomic profiles: toward smart orthopedic device design.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) is a chronic joint disorder characterized by pain, reduced mobility, and structural degeneration. Despite its complex etiology and multi-tissue involvement, the molecular mechanisms underlying OA remain poorly understood. This study aimed to identify tissue-specific diagnostic biomarkers using an integrative framework combining multiple machine learning (ML) algorithms and SHapley Additive exPlanations (SHAP). Gene expression profiles from cartilage, synovium, and peripheral blood were retrieved from the GEO database. DEGs were identified across tissues, followed by feature selection using Least Absolute Shrinkage and Selection Operator(LASSO), Support Vector Machine Recursive Feature Elimination (SVM-RFE), and Random Forest(RF). Functional enrichment, gene set variation analysis (GSVA), and immune infiltration analyses were conducted. 10 ML models were constructed to evaluate diagnostic performance. A total of 8, 28, and 61 DEGs were identified in cartilage, synovium, and blood, respectively. Enrichment analysis revealed the key roles in inflammatory signaling, metabolism, and immune pathways. Biomarkers identified included CSN1S1, ABCA6, RARRES1, NPTX2 (cartilage); SCRG1, CXCL2, PTGDS, CCL19, BGN, KLF9 (synovium); and GNL3L, C6orf111, NT5C3, ZNF148 (blood). Immune analysis indicated shifts in mast cells and CD8 + T cells in cartilage and dendritic cells in synovium, while no significant immune alterations were found in blood. Diagnostic models demonstrated strong performance, with AUCs of 0.839 (cartilage), 0.934 (synovium), and 0.892 (blood). SHAP analysis was employed to interpret each model by quantifying the contribution of individual genes to predict outcomes. In the optimal cartilage model, CSN1S1 and ABCA6 were the most influential features, with mean absolute SHAP values of 0.146 and 0.122, respectively. For synovium, SCRG1 (0.111) and CXCL2 (0.097) were top contributors, while in blood, GNL3L (0.148) and C6orf111 (0.143) showed the highest predictive importance. These results underscore the interpretability of the models and validate the functional relevance of selected biomarkers. Collectively, this study provides a robust ML-based framework for identifying and interpreting reliable OA biomarkers across multiple tissues, offering valuable insights into disease mechanisms and supporting the development of diagnostic tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.